Nearly one in three adults who were still smoking or vaping after a prior ORCA trial had quit at the end of a year of ...

ABU DHABI, 21st October, 2026 (WAM) -- In the presence of H.H. Sheikh Theyab bin Mohamed bin Zayed Al Nahyan, Deputy Chairman of the Presidential Court for Development and Fallen Heroes’ Affairs, the ...

Sleep has moved from a lifestyle concern to a core measure of health, as inadequate sleep affects a substantial share of ...

CEOs of smaller ASX biotechs are paying the price of trial failures, regulatory setbacks and difficult capital markets in ...

In a deep, dark part of the Gulf of Mexico, the number of marine animals plummeted by about 60% in the years following the ...

Science has studied people who came remarkably close to death, but the hardest question still remains beyond direct ...

Where did it start? How did it grow complex? Why did it get big? Three moments in Earth’s early history when evolution ...

Stanford scientists have developed a revolutionary microscope that reveals the hidden inner workings of living cells in real ...

Anavex Life Sciences will proceed with a clinical study of a new drug to treat the genetic disorder Fragile X syndrome after getting clearance from U.S. regulators. The company said the Food and Drug ...

Inc., a privately held clinical-stage biopharmaceutical company developing next-generation therapies for retinal diseases, today announced positive topline results from its BETTIS-1 Phase 2 clinical ...